Intellipharmaceutics International Inc. Quarterly Accounts Payable, Current in USD from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: CAD and USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Intellipharmaceutics International Inc. quarterly Accounts Payable, Current history and growth rate from Q4 2010 to Q3 2023.
  • Intellipharmaceutics International Inc. Accounts Payable, Current for the quarter ending August 31, 2023 was $3.86M, a 9.39% decline year-over-year.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $3.86M -$400K -9.39% Aug 31, 2023 6-K 2023-10-16
Q2 2023 $3.67M -$613K -14.3% May 31, 2023 6-K 2023-09-26
Q1 2023 $3.82M -$75.7K -1.95% Feb 28, 2023 6-K 2023-09-26
Q4 2022 $3.76M -$14.9K -0.39% Nov 30, 2022 20-F/A 2024-02-06
Q3 2022 $4.26M +$486K +12.9% Aug 31, 2022 6-K 2022-10-14
Q2 2022 $4.29M +$199K +4.88% May 31, 2022 6-K 2022-07-21
Q1 2022 $3.89M -$359K -8.46% Feb 28, 2022 6-K 2022-04-14
Q4 2021 $3.78M -$324K -7.91% Nov 30, 2021 20-F/A 2024-02-06
Q3 2021 $3.77M -$296K -7.28% Aug 31, 2021 6-K 2021-10-15
Q2 2021 $4.09M -$211K -4.9% May 31, 2021 6-K 2021-07-15
Q1 2021 $4.25M +$274K +6.88% Feb 28, 2021 6-K 2021-04-14
Q4 2020 $4.1M +$347K +9.24% Nov 30, 2020 20-F/A 2022-05-09
Q3 2020 $4.07M +$564K +16.1% Aug 31, 2020 6-K 2020-10-15
Q2 2020 $4.3M +$1.87M +77% May 31, 2020 6-K 2020-07-15
Q1 2020 $3.98M +$2.21M +125% Feb 29, 2020 6-K 2020-05-29
Q4 2019 $3.76M +$1.11M +42.1% Nov 30, 2019 20-F 2021-03-31
Q3 2019 $3.5M -$2.35M -40.2% Aug 31, 2019 6-K 2019-10-11
Q2 2019 $2.43M -$504K -17.2% May 31, 2019 6-K 2019-07-10
Q1 2019 $1.77M Feb 28, 2019 6-K 2019-04-15
Q4 2018 $2.64M +$583K +28.3% Nov 30, 2018 20-F 2020-03-30
Q3 2018 $5.86M Aug 31, 2018 6-K 2018-10-15
Q2 2018 $2.93M May 31, 2018 6-K/A 2018-07-24
Q4 2017 $2.06M Nov 30, 2017 6-K 2018-10-15
Q4 2015 $3.03M +$2.36M +353% Nov 30, 2015 20-F 2016-03-21
Q4 2014 $668K -$142K -17.6% Nov 30, 2014 20-F 2016-03-21
Q1 2014 $573K Feb 28, 2014 6-K 2014-04-14
Q4 2013 $810K +$298K +58.2% Nov 30, 2013 20-F 2015-02-27
Q4 2012 $512K -$41.9K -7.55% Nov 30, 2012 20-F 2014-02-18
Q4 2011 $554K -$58.7K -9.58% Nov 30, 2011 20-F/A 2013-02-01
Q4 2010 $613K Nov 30, 2010 20-F 2012-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.